A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Trial details
- Registry ID
- NCT05740007
- Drugs studied
- IW-3300 rectal foam
TrialRedline tracks 1 clinical trial sponsored by Ironwood Pharmaceuticals, Inc.: 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeNCT05740007 | IW-3300 rectal foam | Terminated | 2025-01-23Actual |
Names as written in the registry records.